Skip to content

Electra Therapeutics, Inc.

ETRA · XNAS

CIK 2088082fmd_0N7R941VVT25DA34WCY4DEY2QDManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 7 periods

Income Statement · Annual · Millions · USD
Line itemFY2025
Interest expense1
Electra Therapeutics, Inc. (ETRA) financial statements · FinancialMD